Pyxis Oncology, Inc. (PYXS) P/S ratio

P/S ratio today
6.5×

Only 2 fiscal years of P/S ratio are on record here for Pyxis Oncology, Inc. (PYXS); a history needs at least 3. Pyxis Oncology, Inc. (PYXS) trades at 6.5× its revenue per share for fiscal 2025. Figures as of 18 Nov 2026, 09:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
6.5×
P/S ratio, fiscal 2025
5.2×
Change on fiscal 2024
−8.7%
Fiscal years on record
22024–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; 2 are on record here for Pyxis Oncology, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Pyxis Oncology, Inc. P/S ratio, year by year

Pyxis Oncology, Inc. (PYXS) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today6.5×—$1.44—
20255.2× 8.7% down$1.15$0.22
20245.6×—$1.56$0.28
2023——$1.80—
2022——$1.34—
2021——$10.97—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on PYXS

Pyxis Oncology, Inc., figure by figure

Pyxis Oncology, Inc. (PYXS) overview: price, valuation and scorecard

Pyxis Oncology, Inc. P/S ratio: questions and answers

What is Pyxis Oncology, Inc.'s P/S ratio?

Pyxis Oncology, Inc. (PYXS) trades at 6.5× its revenue per share for fiscal 2025.

How is Pyxis Oncology, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Pyxis Oncology, Inc. it is on record here for 2 fiscal years, 2024 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pyxis Oncology, Inc. (PYXS) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/PYXS/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.